Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Epilepsy Drugs Sales Market Report 2021

  • QYR633439
  • 125 Pages
  • July 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies sales (consumption) of Epilepsy Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Eisai

GSK

Pfizer

UCB

AbbVie

Acorda Therapeutics

Alexza Pharmaceuticals

Aprecia Pharmaceuticals

Aurobindo Pharma

Biscayne Pharmaceuticals

CURx Pharmaceuticals

Dainippon Sumitomo Pharma

D-Pharm

F. Hoffmann-La Roche

Grupo Ferrer Internacional

GW Pharmaceuticals

Insero Health

INSYS Therapeutics

Janssen Pharmaceuticals

Ligand Pharmaceuticals

H. Lundbeck

MarcoPolo Pharmaceuticals

Marinus Pharmaceuticals

Meda

Neurelis

Nobelpharma

Novartis

Orphelia Pharma

SAGE Therapeutics

SciFlour

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Epilepsy Drugs in these regions, from 2011 to 2021 (forecast), like

North America

China

Europe

Japan

Southeast Asia

India

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

First-generation Anti-epileptic Drugs

Second-generation Anti-epileptic Drugs

Third-generation Anti-epileptic Drugs

Split by applications, this report focuses on sales, market share and growth rate of Epilepsy Drugs in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Global Epilepsy Drugs Sales Market Report 2021

1 Epilepsy Drugs Overview

1.1 Product Overview and Scope of Epilepsy Drugs

1.2 Classification of Epilepsy Drugs

1.2.1 First-generation Anti-epileptic Drugs

1.2.2 Second-generation Anti-epileptic Drugs

1.2.3 Third-generation Anti-epileptic Drugs

1.3 Applications of Epilepsy Drugs

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Epilepsy Drugs Market by Regions

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Epilepsy Drugs (2011-2021)

1.5.1 Global Epilepsy Drugs Sales, Revenue and Price (2011-2021)

1.5.2 Global Epilepsy Drugs Sales and Growth Rate (2011-2021)

1.5.3 Global Epilepsy Drugs Revenue and Growth Rate (2011-2021)

2 Global Epilepsy Drugs Competition by Manufacturers, Type and Application

2.1 Global Epilepsy Drugs Market Competition by Manufacturers

2.1.1 Global Epilepsy Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Global Epilepsy Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Global Epilepsy Drugs (Volume and Value) by Type

2.2.1 Global Epilepsy Drugs Sales and Market Share by Type (2011-2021)

2.2.2 Global Epilepsy Drugs Revenue and Market Share by Type (2011-2021)

2.3 Global Epilepsy Drugs (Volume and Value) by Regions

2.3.1 Global Epilepsy Drugs Sales and Market Share by Regions (2011-2021)

2.3.2 Global Epilepsy Drugs Revenue and Market Share by Regions (2011-2021)

2.4 Global Epilepsy Drugs (Volume) by Application

3 North America Epilepsy Drugs (Volume, Value and Sales Price

3.1 North America Epilepsy Drugs Sales and Value (2011-2021)

3.1.1 North America Epilepsy Drugs Sales and Growth Rate (2011-2021)

3.1.2 North America Epilepsy Drugs Revenue and Growth Rate (2011-2021)

3.1.3 North America Epilepsy Drugs Sales Price Trend (2011-2021)

3.2 North America Epilepsy Drugs Sales and Market Share by Manufacturers

3.3 North America Epilepsy Drugs Sales and Market Share by Type

3.4 North America Epilepsy Drugs Sales and Market Share by Applications

4 China Epilepsy Drugs (Volume, Value and Sales Price

4.1 China Epilepsy Drugs Sales and Value (2011-2021)

4.1.1 China Epilepsy Drugs Sales and Growth Rate (2011-2021)

4.1.2 China Epilepsy Drugs Revenue and Growth Rate (2011-2021)

4.1.3 China Epilepsy Drugs Sales Price Trend (2011-2021)

4.2 China Epilepsy Drugs Sales and Market Share by Manufacturers

4.3 China Epilepsy Drugs Sales and Market Share by Type

4.4 China Epilepsy Drugs Sales and Market Share by Applications

5 Europe Epilepsy Drugs (Volume, Value and Sales Price

5.1 Europe Epilepsy Drugs Sales and Value (2011-2021)

5.1.1 Europe Epilepsy Drugs Sales and Growth Rate (2011-2021)

5.1.2 Europe Epilepsy Drugs Revenue and Growth Rate (2011-2021)

5.1.3 Europe Epilepsy Drugs Sales Price Trend (2011-2021)

5.2 Europe Epilepsy Drugs Sales and Market Share by Manufacturers

5.3 Europe Epilepsy Drugs Sales and Market Share by Type

5.4 Europe Epilepsy Drugs Sales and Market Share by Applications

6 Japan Epilepsy Drugs (Volume, Value and Sales Price

6.1 Japan Epilepsy Drugs Sales and Value (2011-2021)

6.1.1 Japan Epilepsy Drugs Sales and Growth Rate (2011-2021)

6.1.2 Japan Epilepsy Drugs Revenue and Growth Rate (2011-2021)

6.1.3 Japan Epilepsy Drugs Sales Price Trend (2011-2021)

6.2 Japan Epilepsy Drugs Sales and Market Share by Manufacturers

6.3 Japan Epilepsy Drugs Sales and Market Share by Type

6.4 Japan Epilepsy Drugs Sales and Market Share by Applications

7 Southeast Asia Epilepsy Drugs (Volume, Value and Sales Price

7.1 Southeast Asia Epilepsy Drugs Sales and Value (2011-2021)

7.1.1 Southeast Asia Epilepsy Drugs Sales and Growth Rate (2011-2021)

7.1.2 Southeast Asia Epilepsy Drugs Revenue and Growth Rate (2011-2021)

7.1.3 Southeast Asia Epilepsy Drugs Sales Price Trend (2011-2021)

7.2 Southeast Asia Epilepsy Drugs Sales and Market Share by Manufacturers

7.3 Southeast Asia Epilepsy Drugs Sales and Market Share by Type

7.4 Southeast Asia Epilepsy Drugs Sales and Market Share by Applications

8 India Epilepsy Drugs (Volume, Value and Sales Price

8.1 India Epilepsy Drugs Sales and Value (2011-2021)

8.1.1 India Epilepsy Drugs Sales and Growth Rate (2011-2021)

8.1.2 India Epilepsy Drugs Revenue and Growth Rate (2011-2021)

8.1.3 India Epilepsy Drugs Sales Price Trend (2011-2021)

8.2 India Epilepsy Drugs Sales and Market Share by Manufacturers

8.3 India Epilepsy Drugs Sales and Market Share by Type

8.4 India Epilepsy Drugs Sales and Market Share by Applications

9 Global Epilepsy Drugs Manufacturers Analysis

9.1 Eisai

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Epilepsy Drugs Product Type and Technology

9.1.2.1 First-generation Anti-epileptic Drugs

9.1.2.2 Second-generation Anti-epileptic Drugs

9.1.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2016)

9.2 GSK

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Epilepsy Drugs Product Type and Technology

9.2.2.1 First-generation Anti-epileptic Drugs

9.2.2.2 Second-generation Anti-epileptic Drugs

9.2.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2016)

9.3 Pfizer

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Epilepsy Drugs Product Type and Technology

9.3.2.1 First-generation Anti-epileptic Drugs

9.3.2.2 Second-generation Anti-epileptic Drugs

9.3.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2016)

9.4 UCB

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Epilepsy Drugs Product Type and Technology

9.4.2.1 First-generation Anti-epileptic Drugs

9.4.2.2 Second-generation Anti-epileptic Drugs

9.4.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2016)

9.5 AbbVie

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Epilepsy Drugs Product Type and Technology

9.5.2.1 First-generation Anti-epileptic Drugs

9.5.2.2 Second-generation Anti-epileptic Drugs

9.5.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2016)

9.6 Acorda Therapeutics

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Epilepsy Drugs Product Type and Technology

9.6.2.1 First-generation Anti-epileptic Drugs

9.6.2.2 Second-generation Anti-epileptic Drugs

9.6.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2016)

9.7 Alexza Pharmaceuticals

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Epilepsy Drugs Product Type and Technology

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2017)

9.8 Aprecia Pharmaceuticals

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Epilepsy Drugs Product Type and Technology

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2018)

9.9 Aurobindo Pharma

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Epilepsy Drugs Product Type and Technology

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2019)

9.10 Biscayne Pharmaceuticals

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Epilepsy Drugs Product Type and Technology

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Epilepsy Drugs Sales, Revenue, Price of Company One (2015 and 2021)

9.11 CURx Pharmaceuticals

9.12 Dainippon Sumitomo Pharma

9.13 D-Pharm

9.14 F. Hoffmann-La Roche

9.15 Grupo Ferrer Internacional

9.16 GW Pharmaceuticals

9.17 Insero Health

9.18 INSYS Therapeutics

9.19 Janssen Pharmaceuticals

9.20 Ligand Pharmaceuticals

9.21 H. Lundbeck

9.22 MarcoPolo Pharmaceuticals

9.23 Marinus Pharmaceuticals

9.24 Meda

9.25 Neurelis

9.26 Nobelpharma

9.27 Novartis

9.28 Orphelia Pharma

9.29 SAGE Therapeutics

9.30 SciFlour

10 Epilepsy Drugs Technology and Development Trend

10.1 Epilepsy Drugs Technology Analysis

10.2 Epilepsy Drugs Technology Development Trend

11 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Epilepsy Drugs

Table Classification of Epilepsy Drugs

Figure Global Sales Market Share of Epilepsy Drugs by Type in 2015

Figure First-generation Anti-epileptic Drugs Picture

Figure Second-generation Anti-epileptic Drugs Picture

Figure Third-generation Anti-epileptic Drugs Picture

Table Applications of Epilepsy Drugs

Figure Global Sales Market Share of Epilepsy Drugs by Applications in 2015

Figure North America Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure China Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure Europe Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure Japan Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure India Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Table Global Epilepsy Drugs Sales, Revenue and Price (2011-2021)

Figure Global Epilepsy Drugs Sales and Growth Rate (2011-2021)

Figure Global Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Table Global Epilepsy Drugs Sales of Key Manufacturers (2015 and 2016)

Table Global Epilepsy Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Epilepsy Drugs Sales Share by Manufacturers

Figure 2016 Epilepsy Drugs Sales Share by Manufacturers

Table Global Epilepsy Drugs Revenue by Manufacturers (2015 and 2016)

Table Global Epilepsy Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Epilepsy Drugs Revenue Share by Manufacturers

Table 2016 Global Epilepsy Drugs Revenue Share by Manufacturers

Table Global Epilepsy Drugs Sales and Market Share by Type (2011-2021)

Table Global Epilepsy Drugs Sales Share by Type (2011-2021)

Figure Sales Market Share of Epilepsy Drugs by Type (2011-2021)

Figure Global Epilepsy Drugs Sales Growth Rate by Type (2011-2021)

Table Global Epilepsy Drugs Revenue and Market Share by Type (2011-2021)

Table Global Epilepsy Drugs Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Epilepsy Drugs by Type (2011-2021)

Figure Global Epilepsy Drugs Revenue Growth Rate by Type (2011-2021)

Table Global Epilepsy Drugs Sales and Market Share by Regions (2011-2021)

Table Global Epilepsy Drugs Sales Share by Regions (2011-2021)

Figure Sales Market Share of Epilepsy Drugs by Regions (2011-2021)

Figure Global Epilepsy Drugs Sales Growth Rate by Regions (2011-2021)

Table Global Epilepsy Drugs Revenue and Market Share by Regions (2011-2021)

Table Global Epilepsy Drugs Revenue Share by Regions (2011-2021)

Figure Revenue Market Share of Epilepsy Drugs by Regions (2011-2021)

Figure Global Epilepsy Drugs Revenue Growth Rate by Regions (2011-2021)

Table Global Epilepsy Drugs Sales and Market Share by Application (2011-2021)

Table Global Epilepsy Drugs Sales Share by Application (2011-2021)

Figure Sales Market Share of Epilepsy Drugs by Application (2011-2021)

Figure Global Epilepsy Drugs Sales Growth Rate by Application (2011-2021)

Figure North America Epilepsy Drugs Sales and Growth Rate (2011-2021)

Figure North America Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure North America Epilepsy Drugs Sales Price Trend (2011-2021)

Table North America Epilepsy Drugs Sales by Manufacturers (2015 and 2016)

Table North America Epilepsy Drugs Market Share by Manufacturers (2015 and 2016)

Table North America Epilepsy Drugs Sales by Type (2015 and 2016)

Table North America Epilepsy Drugs Market Share by Type (2015 and 2016)

Table North America Epilepsy Drugs Sales by Applications (2015 and 2016)

Table North America Epilepsy Drugs Market Share by Applications (2015 and 2016)

Figure Europe Epilepsy Drugs Sales and Growth Rate (2011-2021)

Figure Europe Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure Europe Epilepsy Drugs Sales Price Trend (2011-2021)

Table Europe Epilepsy Drugs Sales by Manufacturers (2015 and 2016)

Table Europe Epilepsy Drugs Market Share by Manufacturers (2015 and 2016)

Table Europe Epilepsy Drugs Sales by Type (2015 and 2016)

Table Europe Epilepsy Drugs Market Share by Type (2015 and 2016)

Table Europe Epilepsy Drugs Sales by Applications (2015 and 2016)

Table Europe Epilepsy Drugs Market Share by Applications (2015 and 2016)

Figure China Epilepsy Drugs Sales and Growth Rate (2011-2021)

Figure China Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure China Epilepsy Drugs Sales Price Trend (2011-2021)

Table China Epilepsy Drugs Sales by Manufacturers (2015 and 2016)

Table China Epilepsy Drugs Market Share by Manufacturers (2015 and 2016)

Table China Epilepsy Drugs Sales by Type (2015 and 2016)

Table China Epilepsy Drugs Market Share by Type (2015 and 2016)

Table China Epilepsy Drugs Sales by Applications (2015 and 2016)

Table China Epilepsy Drugs Market Share by Applications (2015 and 2016)

Figure Japan Epilepsy Drugs Sales and Growth Rate (2011-2021)

Figure Japan Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure Japan Epilepsy Drugs Sales Price Trend (2011-2021)

Table Japan Epilepsy Drugs Sales by Manufacturers (2015 and 2016)

Table Japan Epilepsy Drugs Market Share by Manufacturers (2015 and 2016)

Table Japan Epilepsy Drugs Sales by Type (2015 and 2016)

Table Japan Epilepsy Drugs Market Share by Type (2015 and 2016)

Table Japan Epilepsy Drugs Sales by Applications (2015 and 2016)

Table Japan Epilepsy Drugs Market Share by Applications (2015 and 2016)

Figure India Epilepsy Drugs Sales and Growth Rate (2011-2021)

Figure India Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure India Epilepsy Drugs Sales Price Trend (2011-2021)

Table India Epilepsy Drugs Sales by Manufacturers (2015 and 2016)

Table India Epilepsy Drugs Market Share by Manufacturers (2015 and 2016)

Table India Epilepsy Drugs Sales by Type (2015 and 2016)

Table India Epilepsy Drugs Market Share by Type (2015 and 2016)

Table India Epilepsy Drugs Sales by Applications (2015 and 2016)

Table India Epilepsy Drugs Market Share by Applications (2015 and 2016)

Figure Southeast Asia Epilepsy Drugs Sales and Growth Rate (2011-2021)

Figure Southeast Asia Epilepsy Drugs Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Epilepsy Drugs Sales Price Trend (2011-2021)

Table Southeast Asia Epilepsy Drugs Sales by Manufacturers (2015 and 2016)

Table Southeast Asia Epilepsy Drugs Market Share by Manufacturers (2015 and 2016)

Table Southeast Asia Epilepsy Drugs Sales by Type (2015 and 2016)

Table Southeast Asia Epilepsy Drugs Market Share by Type (2015 and 2016)

Table Southeast Asia Epilepsy Drugs Sales by Applications (2015 and 2016)

Table Southeast Asia Epilepsy Drugs Market Share by Applications (2015 and 2016)

Table Eisai Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Eisai (2015 and 2016)

Table GSK Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of GSK (2015 and 2016)

Table Pfizer Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Pfizer (2015 and 2016)

Table UCB Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of UCB (2015 and 2016)

Table AbbVie Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of AbbVie (2015 and 2016)

Table Acorda Therapeutics Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Acorda Therapeutics (2015 and 2016)

Table Alexza Pharmaceuticals Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Alexza Pharmaceuticals (2015 and 2016)

Table Aprecia Pharmaceuticals Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Aprecia Pharmaceuticals (2015 and 2016)

Table Aurobindo Pharma Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Aurobindo Pharma (2015 and 2016)

Table Biscayne Pharmaceuticals Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Biscayne Pharmaceuticals (2015 and 2016)

Table CURx Pharmaceuticals Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of CURx Pharmaceuticals (2015 and 2016)

Table Dainippon Sumitomo Pharma Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Dainippon Sumitomo Pharma (2015 and 2016)

Table D-Pharm Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of D-Pharm (2015 and 2016)

Table F. Hoffmann-La Roche Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)

Table Grupo Ferrer Internacional Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Grupo Ferrer Internacional (2015 and 2016)

Table GW Pharmaceuticals Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of GW Pharmaceuticals (2015 and 2016)

Table Insero Health Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Insero Health (2015 and 2016)

Table INSYS Therapeutics Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of INSYS Therapeutics (2015 and 2016)

Table Janssen Pharmaceuticals Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Janssen Pharmaceuticals (2015 and 2016)

Table Ligand Pharmaceuticals Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Ligand Pharmaceuticals (2015 and 2016)

Table H. Lundbeck Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of H. Lundbeck (2015 and 2016)

Table MarcoPolo Pharmaceuticals Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of MarcoPolo Pharmaceuticals (2015 and 2016)

Table Marinus Pharmaceuticals Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Marinus Pharmaceuticals (2015 and 2016)

Table Meda Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Meda (2015 and 2016)

Table Neurelis Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Neurelis (2015 and 2016)

Table Nobelpharma Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Nobelpharma (2015 and 2016)

Table Novartis Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Novartis (2015 and 2016)

Table Orphelia Pharma Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of Orphelia Pharma (2015 and 2016)

Table SAGE Therapeutics Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of SAGE Therapeutics (2015 and 2016)

Table SciFlour Basic Information List

Table Epilepsy Drugs Sales, Revenue, Price of SciFlour (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390